CanGaroo® Registry Study
- Conditions
- Arrhythmias, Cardiac
- Registration Number
- NCT04846127
- Lead Sponsor
- Aziyo Biologics, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria:<br><br> 1. Participants for whom this is their first CIED implantation at a particular<br> anatomical site.<br><br> Participants with a history of prior CIED implants at other anatomical sites than<br> the current site can be included, provided that the planned implant location for the<br> current CIED procedure is the first implant procedure at that site.<br><br> 2. Participants aged 18 years or older at time of enrollment.<br><br> 3. Participant is able and agrees to provide written informed consent and use of PHI.<br><br>Exclusion Criteria:<br><br> 1. Participants who have had one or more prior CIED procedures (implantations or<br> revisions) at the current device implant site.<br><br> 2. Participants under the age of 18 at time of enrollment.
Not provided
Study & Design
- Study Type
- Observational [Patient Registry]
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association between participant characteristics and outcomes;Association between CanGaroo envelope use and CIED implant-related outcomes and events.
- Secondary Outcome Measures
Name Time Method